Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia

Medicine and Dentistry

• Diabetes Mellitus 100%
• Atypical Antipsychotics 100%
• Treatment of Schizophrenia 100%
• Prevalence 36%
• Typical Antipsychotic 36%
• Diabetes 36%
• Quetiapine 27%
• Olanzapine 27%
• Risperidone 27%
• Clozapine 27%
• Veterans Affairs 18%
• Schizophrenia 18%
• ICD-9 9%
• Maturity Onset Diabetes of the Young 9%
• Multivariate Logistic Regression Analysis 9%
• Outpatient 9%
• Veterans Health 9%
• Diagnosis of Schizophrenia 9%
• Age Groups 9%

Keyphrases

• Schizophrenia Treatment 100%
• Atypical Neuroleptics 100%
• Diabetes Mellitus 100%
• Typical Neuroleptics 36%
• Quetiapine 27%
• Risperidone 27%
• Schizophrenia 18%
• Diabetes Prevalence 18%
• Clozapine Olanzapine 18%
• Age Groups 9%
• ICD-9 9%
• Aging Effect 9%
• Diabetes 9%
• Type 2 Diabetes Mellitus (T2DM) 9%
• 40 Years Old 9%
• Administrative Data 9%
• National Sample 9%
• Olanzapine 9%
• Clozapine 9%
• Administrative Database 9%
• Department of Veterans Affairs 9%
• Diabetes Diagnosis 9%
• Veterans Affairs 9%
• Veterans Health Administration 9%
• Patients with Schizophrenia 9%
• Multiple Logistic Regression 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Diabetes Mellitus 100%
• Atypical Antipsychotics 100%
• Schizophrenia 100%
• Prevalence 36%
• Typical Antipsychotic 36%
• Olanzapine 27%
• Quetiapine 27%
• Risperidone 27%
• Clozapine 27%
• ICD-9 9%
• Maturity Onset Diabetes of the Young 9%